BlackRock’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,565,663
| Closed | -$11.9M | – | 5148 |
|
|
2019
Q1 | $11.9M | Sell |
2,565,663
-114,935
| -4% | -$544K | ﹤0.01% | 3035 |
|
|
2018
Q4 | $9.38M | Sell |
2,680,598
-30,189
| -1% | -$210K | ﹤0.01% | 3122 |
|
|
2018
Q3 | $27.3M | Buy |
2,710,787
+73,282
| +3% | +$585K | ﹤0.01% | 2706 |
|
|
2018
Q2 | $19.1M | Buy |
2,637,505
+193,740
| +8% | +$1.35M | ﹤0.01% | 2889 |
|
|
2018
Q1 | $14.8M | Sell |
2,443,765
-118,680
| -5% | -$980K | ﹤0.01% | 2926 |
|
|
2017
Q4 | $24.6M | Sell |
2,562,445
-159,043
| -6% | -$1.04M | ﹤0.01% | 2673 |
|
|
2017
Q3 | $24.2M | Buy |
2,721,488
+71,819
| +3% | +$741K | ﹤0.01% | 2690 |
|
|
2017
Q2 | $33.5M | Buy |
2,649,669
+16,511
| +0.6% | +$195K | ﹤0.01% | 2481 |
|
|
2017
Q1 | $27.7M | Buy |
2,633,158
+2,595,568
| +6,905% | +$27.7M | ﹤0.01% | 2565 |
|
|
2016
Q4 | $347K | Sell |
37,590
-18,085
| -32% | -$204K | ﹤0.01% | 1848 |
|
|
2016
Q3 | $656K | Buy |
55,675
+10,570
| +23% | +$161K | ﹤0.01% | 1647 |
|
|
2016
Q2 | $584K | Buy |
45,105
+2,187
| +5% | +$31.9K | ﹤0.01% | 1612 |
|
|
2016
Q1 | $687K | Sell |
42,918
-12,354
| -22% | -$235K | ﹤0.01% | 1472 |
|
|
2015
Q4 | $1.58M | Buy |
55,272
+54,852
| +13,060% | +$1.52M | ﹤0.01% | 1167 |
|
|
2015
Q3 | $12K | Hold |
420
| – | – | ﹤0.01% | 2660 |
|
|
2015
Q2 | $15K | Sell |
420
-62
| -13% | -$1.93K | ﹤0.01% | 2563 |
|
|
2015
Q1 | $14K | Hold |
482
| – | – | ﹤0.01% | 2559 |
|
|
2014
Q4 | $10K | Hold |
482
| – | – | ﹤0.01% | 2794 |
|
|
2014
Q3 | $9K | Hold |
482
| – | – | ﹤0.01% | 2823 |
|
|
2014
Q2 | $8K | Buy |
482
+104
| +28% | +$1.68K | ﹤0.01% | 2959 |
|
|
2014
Q1 | $8K | Hold |
378
| – | – | ﹤0.01% | 2882 |
|
|
2013
Q4 | $5K | Hold |
378
| – | – | ﹤0.01% | 3060 |
|
|
2013
Q3 | $4K | Hold |
378
| – | – | ﹤0.01% | 3047 |
|
|
2013
Q2 | $2K | Buy |
+378
| New | +$1.39K | ﹤0.01% | 3107 |
|
Other funds holding INSY
WS
BlackRock's INSY Position: Q2 2019 in Review
BlackRock sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 2,565,663 shares — an estimated $11.9M sold.
BlackRock first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $33.5M in Q2 2017. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- BlackRock reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- BlackRock sold 2,565,663 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $11.9M.
- BlackRock first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- BlackRock's Insys Therapeutics, Inc. position peaked at $33.5M in Q2 2017.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on BlackRock's 13F filing for Q2 2019, filed 13 Aug 2019.